Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
3(19%)
Results Posted
29%(2 trials)

Phase Distribution

Ph not_applicable
7
44%
Ph phase_3
2
13%
Ph phase_4
7
44%

Phase Distribution

0

Early Stage

0

Mid Stage

9

Late Stage

Phase Distribution16 total trials
Phase 3Large-scale testing
2(12.5%)
Phase 4Post-market surveillance
7(43.8%)
N/ANon-phased studies
7(43.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

3

trials recruiting

Total Trials

16

all time

Status Distribution
Active(8)
Completed(7)
Terminated(1)

Detailed Status

Completed7
Not yet recruiting5
Recruiting3
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
16
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 32 (12.5%)
Phase 47 (43.8%)
N/A7 (43.8%)

Trials by Status

completed744%
withdrawn16%
not_yet_recruiting531%
recruiting319%

Recent Activity

Clinical Trials (16)

Showing 16 of 16 trials
NCT07306702Phase 4

Dexmedetomidine-Enhanced PCIA After Lobectomy in Nicotine-Dependent Patients

Withdrawn
NCT07479446Not Applicable

Oliceridine Versus Sufentanil for Postoperative Nausea in Cerebellopontine Angle Surgery

Not Yet Recruiting
NCT07372209Not Applicable

Effects and Safety of Oliceridine in Anesthesia Induction:A Randomised Controlled Trial

Completed
NCT07018375Phase 4

The Effect of Oliceridine Patient-Controlled Intravenous Analgesia on Postoperative Chronic Pain After Video-Assisted Thoracoscopic Lobectomy

Not Yet Recruiting
NCT07187765Not Applicable

Respiratory Safety of Oliceridine During Sedated Gastrointestinal Endoscopy

Completed
NCT04979247Phase 4

Intravenous Oliceridine and Opioid-related Complications

Completed
NCT07112157Not Applicable

Efficacy of Oxalidine and Sufentanil in Strabismus Correction

Not Yet Recruiting
NCT07097038Not Applicable

Analgesic Effect and Safety of Oliceridine and Oxycodone in Vitrectomy

Not Yet Recruiting
NCT07026162Phase 4

Oliceridine on Postoperative Nausea and Vomiting in Gynecological Laparoscopic Surgery

Recruiting
NCT06990893Not Applicable

Comparison of the Analgesic Effect of Oliceridine Versus Morphine or Sufentanil for Postoperative Analgesia in Lumbar Surgeries: a Randomized Control Trial

Recruiting
NCT06458400Phase 4

To Evaluate the Efficacy and Safety of Tegileridine and Oliceridine Injections in the Treatment of Postoperative Pain

Completed
NCT06668298Not Applicable

Clinical Study of G Protein Biased Μ - Opioid Receptor Agonist Oliceridine for Optimizing Postoperative Analgesia Under General Anesthesia

Not Yet Recruiting
NCT06411665Phase 4

Effect of Oliceridine Analgesia on Postoperative Nause and Vomiting

Recruiting
NCT05465226Phase 4

Oliceridine in Patients With Acute Burn Injuries

Completed
NCT02820324Phase 3

Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Abdominoplasty

Completed
NCT02815709Phase 3

Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Bunionectomy

Completed

All 16 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
16